Donaldson Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-443
| Closed | -$221K | – | 223 |
|
|
2025
Q1 | $221K | Sell |
443
-272
| -38% | -$135K | 0.01% | 212 |
|
|
2024
Q4 | $372K | Sell |
715
-6,026
| -89% | -$3.13M | 0.01% | 183 |
|
|
2024
Q3 | $4.17M | Buy |
6,741
+107
| +2% | +$66.2K | 0.16% | 66 |
|
|
2024
Q2 | $3.67M | Buy |
6,634
+352
| +6% | +$195K | 0.15% | 69 |
|
|
2024
Q1 | $3.65M | Buy |
6,282
+561
| +10% | +$326K | 0.15% | 73 |
|
|
2023
Q4 | $3.04M | Buy |
5,721
+531
| +10% | +$282K | 0.14% | 76 |
|
|
2023
Q3 | $2.63M | Sell |
5,190
-286
| -5% | -$145K | 0.12% | 78 |
|
|
2023
Q2 | $2.86M | Buy |
5,476
+59
| +1% | +$30.8K | 0.13% | 76 |
|
|
2023
Q1 | $3.12M | Buy |
5,417
+609
| +13% | +$351K | 0.15% | 77 |
|
|
2022
Q4 | $2.65M | Sell |
4,808
-1,738
| -27% | -$957K | 0.13% | 82 |
|
|
2022
Q3 | $3.32M | Buy |
6,546
+5,417
| +480% | +$2.75M | 0.18% | 68 |
|
|
2022
Q2 | $613K | Sell |
1,129
-14
| -1% | -$7.6K | 0.03% | 142 |
|
|
2022
Q1 | $675K | Sell |
1,143
-112
| -9% | -$66.1K | 0.03% | 154 |
|
|
2021
Q4 | $837K | Sell |
1,255
-11
| -0.9% | -$7.34K | 0.04% | 137 |
|
|
2021
Q3 | $723K | Buy |
1,266
+37
| +3% | +$21.1K | 0.04% | 142 |
|
|
2021
Q2 | $620K | Sell |
1,229
-249
| -17% | -$126K | 0.03% | 150 |
|
|
2021
Q1 | $674K | Buy |
1,478
+50
| +4% | +$22.8K | 0.04% | 137 |
|
|
2020
Q4 | $665K | Sell |
1,428
-494
| -26% | -$230K | 0.04% | 128 |
|
|
2020
Q3 | $849K | Buy |
1,922
+298
| +18% | +$132K | 0.06% | 102 |
|
|
2020
Q2 | $589K | Buy |
1,624
+38
| +2% | +$13.8K | 0.04% | 119 |
|
|
2020
Q1 | $450K | Buy |
1,586
+298
| +23% | +$84.6K | 0.04% | 118 |
|
|
2019
Q4 | $418K | Buy |
1,288
+259
| +25% | +$84.1K | 0.03% | 148 |
|
|
2019
Q3 | $300K | Buy |
+1,029
| New | +$300K | 0.02% | 166 |
|